SecBot SecBot
144 ·Filed Nov 9, 2026

TMDX

TransMedics Group, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed7d 9h ago SEC0001950047-26-010898
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The proposed sale is small relative to market cap and appears to be a routine diversification move by a director. Monitor whether the sale actually executes and if other insiders follow with similar filings.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1
Entry
$90.95
T+0 close · Nov 9, 2026 · via day close
Latest settled
+1.17%
T+1 · $92.01 · next T+5 in 4h
Vs SPY
−0.15%
α at T+1
Latest observation
+4.64%
T+4 · FF3 residual α
  1. T+0 · Nov 10 $90.95entry
  2. T+1 · 6d ago +1.17%α −0.15% · $92.01
  3. T+4 · todayOpen
  4. T+5 · in 4h Pending
  5. T+20 · in 22d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director James R. Tobin filed a Form 144 notice of intent to sell 4,059 shares of TransMedics Group, Inc. common stock, with an estimated aggregate market value of approximately $385,468 based on the filing date. The shares were acquired through restricted stock grants in 2024, 2025, and 2026, and the sale is planned for or around November 9, 2026.

Key Facts

  • James R. Tobin, a director of TransMedics Group, Inc., filed a Form 144 on November 9, 2026.
  • The proposed sale involves 4,059 shares of common stock.
  • Estimated aggregate market value of the proposed sale is approximately $385,468.
  • Shares were acquired via restricted stock grants on May 23, 2024 (1,193 shares), May 22, 2025 (732 shares), and May 20, 2026 (2,134 shares).
  • The sale is intended to be executed through Morgan Stanley Smith Barney LLC.

Financial Impact

Proposed sale of 4,059 shares valued at ~$385,468, representing a small fraction of the company's $2.4B market cap (approximately 0.016%).

dilution

Risk Factors

  • Form 144 is an intent to sell; the actual sale may not occur.
  • No information on the director's remaining holdings, so the proportional impact on his personal position is unknown.

Market Snapshot

Exchange
Nasdaq
Sector
Electromedical & Electrotherapeutic Apparatus
Analyst Consensus
74% bullish (19 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010898
Document: 0001950047-26-010898-index.html0001950047-26-010898
Document: 0001950047-26-010898.txt0001950047-26-010898

Track record

9 reports on TMDX

Performance horizon

3 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +22.27% at T+60 after the Jun 11, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 9, 20267d ago 144 Neutral 2/10 Viewing Entry $90.95 Now $92.21 +1.39% settles Nov 17
  2. Nov 5, 202611d ago 8-K Bullish 6/10 Entry $88.24 to $91.38 Now $92.21 +4.50% ▲ +3.56% +0.96% vs SPY
  3. Nov 5, 202611d ago Press Release Bullish 6/10 No price data
  4. Jun 12, 202622w ago Institutional Cluster Bullish 6/10 Entry $72.91 to $78.79 Now $92.21 +26.47% ▲ +8.06% +7.39% vs SPY
  5. Jun 11, 202622w ago Institutional Cluster Bullish 5/10 Entry $73.59 to $73.22 Now $92.21 +25.30% ▼ −0.50% −0.94% vs SPY
  6. Apr 10, 202631w ago DEFA14A Neutral 3/10 Entry $114.00 to $115.87 Now $92.21 −19.11% ▲ +1.64% −2.86% vs SPY
  7. Mar 2, 202637w ago Insider Cluster Neutral 3/10 Entry $147.00 to $134.77 Now $92.21 −37.27% ▼ −8.32% −7.11% vs SPY
  8. Feb 27, 202637w ago 8-K Neutral 4/10 Entry $145.26 to $129.61 Now $92.21 −36.52% ▼ −10.77% −8.79% vs SPY
  9. Feb 24, 202637w ago 8-K Bullish 8/10 Entry $131.85 to $147.66 Now $92.21 −30.06% ▲ +11.99% +13.09% vs SPY
Showing 9 of 9

US Market Status

Market Closed · Opens in 6h 12m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 9, 2026